GIMIGELA
Live / Applied — Third extension granted (statement of use) (as of 23 Oct 2025)
What this means for you
Not registered yet, but its 09 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97928201
- Mark type
- Stylized text
- Filed
- 09 May 2023
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of metabolic, endocrine, diabetes and obesity-related diseases and disorders
- Class 042 — Scientific and technological services: Medical and scientific research and development in the fields of metabolic, endocrine, diabetes and obesity-related diseases and disorders and providing medical and scientific research information services
Owner
- Structure Therapeutics USA Inc., South San Francisco, CA, US
- Structure Therapeutics USA Inc., South San Francisco, CA, US
Prosecution history
- 24 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2025 — SOU EXTENSION 3 GRANTED
- 23 Oct 2025 — SOU EXTENSION 3 FILED
- 23 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Apr 2025 — SOU EXTENSION 2 GRANTED
- 14 Apr 2025 — SOU EXTENSION 2 FILED
- 14 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2024 — SOU EXTENSION 1 GRANTED
- 20 Sept 2024 — SOU EXTENSION 1 FILED
- 20 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 25 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED